plerixafor has been researched along with Wiskott-Aldrich Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apperley, JF; Basak, GW; Douglas, KW; Duarte, RF; Gabriel, IH; Geraldes, C; Hübel, K; Jaksic, O; Koristek, Z; Lanza, F; Lemoli, R; Mikala, G; Mohty, M; Selleslag, D; Worel, N | 1 |
1 other study(ies) available for plerixafor and Wiskott-Aldrich Syndrome
Article | Year |
---|---|
European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antineoplastic Agents; Benzylamines; Blood Component Removal; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclams; Europe; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Male; Middle Aged; Neoplasms; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Sarcoma, Ewing; Stem Cell Transplantation; Wiskott-Aldrich Syndrome; Young Adult | 2012 |